menu search

BioCardia Letter to Shareholders

BioCardia Letter to Shareholders
SUNNYVALE, Calif., Dec. 22, 2022 (GLOBE NEWSWIRE) — BioCardia, Inc. (Nasdaq: BCDA), a clinical-stage developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases issued the following letter to shareholders: Dear Shareholders,BioCardia is now advancing four novel cell therapies, with three focused on heart disease, a leading cause of death and reduced […] The post BioCardia Letter to Shareholders appeared first on ForexTV... Read More
Posted: Dec 22 2022, 12:00
Author Name: forextv
Views: 110287

Search within

Pages Search Results: